# Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents

> **NCT01431950** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 238 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** fluticasone furoate
- **DRUG:** albuterol/salbutamol

## Key facts

- **NCT ID:** NCT01431950
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 238 (ACTUAL)
- **Last updated:** 2017-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01431950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01431950, "Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01431950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*